Download
The increasing complexity of immuno-oncology experiments and the expanding development of treatments drive the need for even more commercially available reagents that scientists can trust. While primary antibodies usually get the most attention from researchers, secondary antibodies are often crucial for the success of an experiment. From basic research in immuno-oncology to diagnostics and treatments, secondary antibodies improve imaging and flow-based work. In supporting immuno-oncology, Jackson ImmunoResearch provides a wide range of secondary antibodies and their respective reporter conjugates.
